| GCFLU GREEN CROSS CORPORATION
79213938 28 Apr 2017 | on 29 May 2018 | Pharmaceutical preparations for treating the central nervous system; [... Class 005 Class 005 Pharmaceutical Products In the statement, Class 5, has been updated in accordance with the F-note dated 3/8/2021. | | | EUGAMM Green Cross Corporation
90160128 04 Sep 2020 | on 22 Jul 2024
| Blood plasma derivatives for medical purposes, namely, immune globulin... Class 005 Class 005 Pharmaceutical Products Blood plasma derivatives for medical purposes, namely, immune globulins including Rh immune globulin; Immunoglobulin preparations, namely, pharmaceutical immunoglobulin preparations for diagnosis of primary humoral immunodeficiency, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich syndrome, severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP), for preventing primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP), and for treatment of primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich Syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP) | | | AMGLOBIA Green Cross Corporation
90160141 04 Sep 2020 | on 22 Jul 2024
| Blood plasma derivatives for medical purposes, namely, immune globulin... Class 005 Class 005 Pharmaceutical Products Blood plasma derivatives for medical purposes, namely, immune globulins including Rh immune globulin; Immunoglobulin preparations, namely, pharmaceutical immunoglobulin preparations for diagnosis of primary humoral immunodeficiency, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich syndrome, severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP), for preventing primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP), and for treatment of primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich Syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP) | | | IRIFAZE Green Cross Corporation
87166568 09 Sep 2016 | on 10 May 2024 | Medicines for treatment of mucopolysaccharidoses; Medicines for treati... Class 005 Class 005 Pharmaceutical Products Medicines for treatment of mucopolysaccharidoses; Medicines for treating metabolism disorder; Bacteriological preparations for medical use; Medicines for treatment of hunter syndrome; Medicines for treating enzyme deficiency; Medicines for treatment of sensory organ diseases; Medicines for treatment of peripheral nervous system disorders; Immunomodulator; Preparations of trace elements for human and animal use, namely, enzymes for medical purposes, enzymes for veterinary purposes, and dietary and nutritional supplements; Medicines for treatment of digestive organ diseases; Medicines for treatment of circulatory organ disorders; Allergy medicines; Cultures of microorganisms for medical use in the nature of cultures for cultivating enzymes; Biological preparations for medical use, namely, biological preparations for treatment of enzyme disorders and enzyme deficiencies; Medicines for treatment of central nervous system disorders; Medicines for treatment of respiratory organ diseases | | | TRUPLAZE Green Cross Corporation
87166553 09 Sep 2016 | on 10 May 2024 | Medicines for treatment of mucopolysaccharidoses; Medicines for treati... Class 005 Class 005 Pharmaceutical Products Medicines for treatment of mucopolysaccharidoses; Medicines for treating metabolism disorder; Bacteriological preparations for medical use; Medicines for treatment of hunter syndrome; Medicines for treating enzyme deficiency; Medicines for treatment of sensory organ diseases; Medicines for treatment of peripheral nervous system disorders; Immunomodulator; Preparations of trace elements for human and animal use, namely, enzymes for medical purposes, enzymes for veterinary purposes, and dietary and nutritional supplements; Medicines for treatment of digestive organ diseases; Medicines for treatment of circulatory organ disorders; Allergy medicines; Cultures of microorganisms for medical use in the nature of cultures for cultivating enzymes; Biological preparations for medical use, namely, biological preparations for treatment of enzyme disorders and enzyme deficiencies; Medicines for treatment of central nervous system disorders; Medicines for treatment of respiratory organ diseases | | | EUGAMMA Green Cross Corporation
86739492 27 Aug 2015 | on 05 May 2023 | Pharmaceutical preparations, namely, Intravenous immunoglobulin (IVIG) Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, Intravenous immunoglobulin (IVIG) | | | ELGAMMA Green Cross Corporation
86739462 27 Aug 2015 | on 05 May 2023 | Pharmaceutical preparations, namely, Intravenous immunoglobulin (IVIG) Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, Intravenous immunoglobulin (IVIG) | | | HUNTERASE Green Cross Corporation
76720329 20 Mar 2013 | on 08 Feb 2021 | Medicines for treatment of mucopolysaccharidoses; medicines for treati... Class 005 Class 005 Pharmaceutical Products 79129306 | | | HUNTERASE GREEN CROSS CORPORATION
79129306 20 Mar 2013 | on 25 Aug 2017 | Medicines for treatment of mucopolysaccharidoses; medicines for treati... Class 005 Class 005 Pharmaceutical Products 76720329 | |